Cargando…
Olesoxime (TRO19622): A Novel Mitochondrial-Targeted Neuroprotective Compound
Olesoxime (TRO19622) is a novel mitochondrial-targeted neuroprotective compound undergoing a pivotal clinical efficacy study in Amyotrophic Lateral Sclerosis (ALS) and also in development for Spinal Muscular Atrophy (SMA). It belongs to a new family of cholesterol-oximes identified for its survival-...
Autores principales: | Bordet, Thierry, Berna, Patrick, Abitbol, Jean-Louis, Pruss, Rebecca M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033913/ https://www.ncbi.nlm.nih.gov/pubmed/27713255 http://dx.doi.org/10.3390/ph3020345 |
Ejemplares similares
-
TRO40303, a mitochondrial-targeted cytoprotective compound, provides protection in hepatitis models
por: Schaller, Sophie, et al.
Publicado: (2015) -
Translation of TRO40303 from myocardial infarction models to demonstration of safety and tolerance in a randomized Phase I trial
por: Le Lamer, Sophie, et al.
Publicado: (2014) -
TRO40303 Ameliorates Alcohol-Induced Pancreatitis Through Reduction of Fatty Acid Ethyl Ester–Induced Mitochondrial Injury and Necrotic Cell Death
por: Javed, Muhammad Ahsan, et al.
Publicado: (2018) -
The calpain-suppressing effects of olesoxime in Huntington's disease
por: Weber, Jonasz J., et al.
Publicado: (2016) -
Olesoxime Inhibits Cardioplegia-Induced Ischemia/Reperfusion Injury. A Study in Langendorff-Perfused Rabbit Hearts
por: Salameh, Aida, et al.
Publicado: (2017)